You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a 66-year-old woman in fairly good health, but I have ...

A full in-basket of messages from patients in a physician’s electronic health record doesn’t add to clinician burnout, but messages loaded with curse words might perhaps help point the way toward how ...

Trial met primary long episode endpoints with high statistical significance, and RAP-219 was generally well tolerated Patients achieved 77.8% reduction in clinical seizures (p=0.01), with 24% ...

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire treatment period, along with consistent efficacy data regardless of patients’ ...

My mother, who's 89, thinks FaceTime involves a washcloth and some CoverGirl. So, she was understandably puzzled when I sat her in front of a computer for her first-ever telehealth visit. "I don't ...

I have had many patients recently comment about how they would never be able to find their way around without their smart phones. I have yet to use such a gadget to get around, as I actually enjoy ...

Navy Lt. Chandra Carney, a physician assistant (PA) in the internal medicine department, Bravo medical home team at Walter Reed National Military Medical Center (WRNMMC), starts the work day with a ...

Dear Dr. Roach: I am a 66-year-old woman in fairly good health, but I have visited enough doctors recently to make the following observation: Almost without fail, a person will enter the examination ...

(MENAFN- GlobeNewsWire - Nasdaq) Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire treatment period, along with consistent ...

BOSTON and SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (Rapport or the Company), a clinical-stage biotechnology company dedicated to the discovery and ...

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures Rapport Therapeutics, Inc ...